Replies to post #250643 on Biotech Values

[DewDiligence]

XOMA acquires KNTE for $2.3352-to-$2.5879 cash +CVR—an 8% premium to yesterday’s close at the midpoint of the cash range (excluding the CVR):

https://finance.yahoo.com/news/xoma-enters-agreement-acquire-kinnate-130000871.html

The cash portion if the deal is a range because the amount depends on how much working capital KNTE has when the merger closes.